OncoMed Pharmaceuticals Inc. buy melinda
Start price
04.01.17
/
50%
€7.21
Target price
27.02.17
€9.02
Performance (%)
25.78%
End price
27.02.17
€9.07
Summary
This prediction ended on 27.02.17 with a price of €9.07. The BUY prediction by melinda finished with a performance of 25.78%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
OncoMed Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 1.395% | -0.696% | 15.472% | 15.907% |
iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% | 53.474% |
iShares Nikkei 225® | 1.617% | 2.769% | 11.442% | 8.194% |
iShares S&P 500 | 0.659% | 4.280% | 26.778% | 45.322% |
Comments by melinda for this prediction
In the thread OncoMed Pharmaceuticals Inc. diskutieren
Stier
$ OMED Registriert P1b Clin. Bispezifischen Antikörper - Test DLL4 / Anti-VEGF als zweiter Linie Trtmnt Mets. Darmkrebs
(Zielkurs erreicht)
Stopped prediction by melinda for OncoMed Pharmaceuticals Inc.
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.88
17.03.19
17.03.19
€1.13
25.04.19
25.04.19
-8.72%
25.04.19
25.04.19
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.71
24.10.18
24.10.18
€2.16
22.01.19
22.01.19
-58.25%
22.01.19
22.01.19
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.48
14.04.17
14.04.17
€7.67
22.08.17
22.08.17
10.88%
22.08.17
22.08.17
OncoMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.13
04.12.13
04.12.13
€19.00
04.06.14
04.06.14
0.00%
04.06.14
04.06.14